Assessment of Zegerid on Esophageal pH in Patients With Barrett's Esophagus

NCT01129778 · clinicaltrials.gov ↗

NA

Phase

TERMINATED

Status

27

Enrollment

OTHER

Sponsor class

Stopped change in the business strategy of the sponsor

Conditions

Barrett Esophagus
Gastroesophageal Reflux

Interventions

DRUG: Zegerid (proton pump inhibitor)
PROCEDURE: Bravo pH monitoring

Sponsor

Stanford University